Revenue Comparison
Chart: Revenue Comparison. Values in USD_BILLIONS. In Q1 2026: Pfizer 14.451, Sanofi 13.284.
Pfizer vs Sanofi Net Worth and Market Cap
Pfizer (PFE) and Sanofi (SNY) are peers in Vaccines. Pfizer reported revenue of $14.5B as of Q1 2026, compared with $13.3B for Sanofi. Pfizer leads on revenue.
Pfizer's gross margin is 67.3% versus 75.5% for Sanofi. Pfizer's net margin is 18.6% versus 2.8% for Sanofi.
Latest Quarter Comparison
Table: Latest Quarter Comparison. 15 rows across Metric, Pfizer, Sanofi.| Metric | Pfizer | Sanofi |
|---|---|---|
| Market Cap | - | - |
| Revenue | $14.45B | $13.28B |
| Cost of Revenue | $4.73B | $3.26B |
| Gross Profit | $9.72B | $10.03B |
| Operating Income | $4.03B | $2.58B |
| Net Income | $2.69B | $370.00M |
| R&D Expense | $2.63B | $2.41B |
| Earnings Per Share | $0.47 | $0.15 |
| Gross Margin | 67.3% | 75.5% |
| Operating Margin | 27.9% | 19.4% |
| Net Profit Margin | 18.6% | 2.8% |
| Free Cash Flow | $2.18B | $4.22B |
| Cumulative Free Cash Flow | $356.40B | $51.81B |
| Operating Cash Flow | $2.62B | $5.85B |
| Cash & Equivalents | $1.70B | $6.86B |
Prefer Sterling in Google
Add sterlingcharts.com as a preferred source so our charts can appear with a preferred badge in Google Top Stories, AI Mode, and AI Overviews.